| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $40,093 | 2 | 33 |
Sells | $2,619,180 | 4 | 67 |
| Driscoll Michael Joseph | director | 1 | $26,688 | 0 | $0 | $26,688 |
| Leibowitz Arthur S | director | 1 | $13,405 | 0 | $0 | $13,405 |
| NUSSDORF GLENN H | 0 | $0 | 4 | $2.62M | $-2.62M |
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed to preserve vital cells, growth factors, and ECM proteins found in natural tissue. Apligraf is a bioengineered living cell therapy that releases a …
Over the last 12 months, insiders at Organogenesis Holdings Inc. have bought $40,093 and sold $2.62M worth of Organogenesis Holdings Inc. stock.
On average, over the past 5 years, insiders at Organogenesis Holdings Inc. have bought $636,111 and sold $1.81M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Driscoll Michael Joseph (director) — $26,688. Leibowitz Arthur S (director) — $13,405.
The last purchase of 5,000 shares for transaction amount of $13,405 was made by Leibowitz Arthur S (director) on 2026‑03‑09.
| 2026-03-09 | Leibowitz Arthur S | director | 5,000 0.0037% | $2.68 | $13,405 | -14.31% | ||
| 2026-03-09 | Driscoll Michael Joseph | director | 10,000 0.0074% | $2.67 | $26,688 | -14.31% | ||
| 2025-12-16 | Sale | NUSSDORF GLENN H | director | 200,000 0.1565% | $5.14 | $1.03M | -53.19% | |
| 2025-11-26 | Sale | NUSSDORF GLENN H | 187,957 0.1445% | $5.29 | $994,293 | -55.17% | ||
| 2025-11-25 | Sale | NUSSDORF GLENN H | 12,043 0.009% | $5.30 | $63,828 | -53.98% | ||
| 2025-11-24 | Sale | NUSSDORF GLENN H | 100,000 0.0753% | $5.34 | $534,000 | -54.82% | ||
| 2025-06-10 | Sale | NUSSDORF GLENN H | 18,620 0.0151% | $3.56 | $66,256 | +17.00% | ||
| 2025-06-09 | Sale | NUSSDORF GLENN H | 4,156 0.0033% | $3.50 | $14,547 | +18.02% | ||
| 2025-06-06 | Freedman Lori | Chief Admin. and Legal Officer | 9,022 0.007% | $2.99 | $26,949 | +34.16% | ||
| 2025-06-05 | Freedman Lori | Chief Admin. and Legal Officer | 142,379 0.1132% | $2.91 | $413,625 | +40.97% | ||
| 2025-06-04 | Freedman Lori | Chief Admin. and Legal Officer | 100,863 0.0785% | $2.82 | $284,716 | +41.96% | ||
| 2025-05-15 | NUSSDORF GLENN H | 107,494 0.0835% | $2.99 | $320,999 | +33.99% | |||
| 2025-05-14 | NUSSDORF GLENN H | 251,001 0.203% | $3.09 | $775,041 | +34.88% | |||
| 2025-03-04 | Sale | Driscoll Michael Joseph | director | 25,000 0.02% | $5.10 | $127,535 | -13.69% | |
| 2024-12-16 | Sale | Gillheeney Gary S. | President and CEO | 5,585 0.0042% | $3.49 | $19,492 | +20.00% | |
| 2024-12-13 | Sale | Gillheeney Gary S. | President and CEO | 55,615 0.0414% | $3.36 | $186,866 | +25.29% | |
| 2024-12-12 | Sale | Gillheeney Gary S. | President and CEO | 43,359 0.0332% | $3.55 | $153,924 | +20.54% | |
| 2024-12-11 | Sale | Gillheeney Gary S. | President and CEO | 157,448 0.1179% | $3.64 | $573,111 | +16.12% | |
| 2024-12-10 | Sale | Gillheeney Gary S. | President and CEO | 58,525 0.044% | $3.64 | $213,031 | +15.49% | |
| 2024-12-09 | Sale | Gillheeney Gary S. | President and CEO | 41,052 0.031% | $3.52 | $144,503 | +21.43% |
| NUSSDORF GLENN H | director | 2565591 1.9939% | $2.14M | 8 | 8 | +29.65% |
| Leibowitz Arthur S | director | 291014 0.2262% | $242,996.69 | 4 | 0 | +69.17% |
| Driscoll Michael Joseph | director | 225707 0.1754% | $188,465.35 | 2 | 1 | <0.0001% |
| Ades Alan A. | 59836745 46.5024% | $49.96M | 5 | 2 | +41.72% | |
| GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | 10 percent owner | 59448027 46.2003% | $49.64M | 1 | 0 | <0.0001% |
| Avista Capital Managing Member IV, LLC | 29924515 23.256% | $24.99M | 18 | 0 | +53.22% | |
| Freedman Lori | Chief Admin. and Legal Officer | 846459 0.6578% | $706,793.27 | 3 | 0 | +39.03% |
| MARKISON BRIAN A | director | 775000 0.6023% | $647,125.00 | 2 | 0 | |
| MACKIE WAYNE D | director | 200000 0.1554% | $167,000.00 | 9 | 0 | +33.4% |
| KATZ MICHAEL W | director | 76382 0.0594% | $63,778.97 | 15 | 0 | <0.0001% |
$2,101,005 | 2135 | -11.51% | $64.58M | |
Organogenesis Holdings Inc. (ORGO) | $131,310,609 | 62 | 26.99% | $107.44M |
$2,767,882 | 51 | 8.70% | $24.78M | |
$30,221,759 | 51 | 0.50% | $20.6M | |
$33,884,330 | 45 | 12.56% | $223.45M |
| Increased Positions | 76 | +57.14% | 9M | +12.82% |
| Decreased Positions | 55 | -41.35% | 8M | -11.87% |
| New Positions | 33 | New | 2M | New |
| Sold Out Positions | 9 | Sold Out | 96,292 | Sold Out |
| Total Postitions | 154 | +15.79% | 69M | +0.95% |
| Soleus Capital Management, L.P. | $56,230.00 | 9.55% | 12.13M | -211,652 | -1.72% | 2025-09-30 |
| Morgan Stanley | $54,678.00 | 9.29% | 11.8M | -259,222 | -2.15% | 2025-09-30 |
| First Light Asset Management, Llc | $34,753.00 | 5.9% | 7.5M | +720,748 | +10.63% | 2025-09-30 |
| Vanguard Group Inc | $23,342.00 | 3.97% | 5.04M | -160,772 | -3.09% | 2025-09-30 |
| Assenagon Asset Management S.A. | $22,503.00 | 3.82% | 4.85M | +2M | +69.88% | 2025-09-30 |
| Blackrock, Inc. | $21,251.00 | 3.61% | 4.58M | -148,992 | -3.15% | 2025-09-30 |
| Deutsche Bank Ag | $15,223.00 | 2.59% | 3.28M | +6,381 | +0.2% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $13,484.00 | 2.29% | 2.91M | -195,322 | -6.29% | 2025-09-30 |
| Acadian Asset Management Llc | $8,126.00 | 1.38% | 1.75M | -671,133 | -27.68% | 2025-09-30 |
| Geode Capital Management, Llc | $7,994.00 | 1.36% | 1.72M | +50,766 | +3.03% | 2025-09-30 |